Abstract
Disease Activity as Assessed by the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) Score Predicts Long-Term Clinical Disease Activity (CDA)-Free Status and Disability Progression in Patients Treated with Subcutaneous Interferon beta-1a (scIFNβ-1a) (S24.005)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have